10.1111/rda.13314 110 MarinaroF.Macas-GarcaB.Snchez-MargalloF
While our [BPC 157 Capsules]( are excellent for gut-focused research due to their stability in gastric acid, injectable BPC-157 has higher bioavailability for systemic effects
The main efficacy-related conclusions of this review are: (a) medications demonstrated the strongest and most consistent effects on core ADHD symptoms (especially inattention), (b) heterogeneous C/BTs demonstrated inconsistent effects on ADHD symptoms, strong consistent effects on impairment and executive function skills, and modest consistent effects on internalizing symptoms and analogue note-taking performance, (c) C/BTs demonstrated consistent maintenance effects for executive function skills and impairment up to 6 months and possibly 3 years post-treatment, (d) though comparing the efficacy of two C/BTs rarely led to significant differences, which C/BT worked best for whom could be reliably predicted from patient- and provider-level moderators

Observed Structural and Functional Outcomes Post-treatment evaluation revealed measurable changes, including: Increased intervertebral disc height (approximately 2025%) Reduction in herniation dimensions on MRI Improved spinal alignment Substantial functional improvement, with ODI scores decreasing from 70% to 20% While the authors emphasized that these findings represent observations from a single case, the results highlight why the intervertebral disc is considered a compelling target for regenerative research